Via Falloppio, 61 - PADOVA
+39.049.8751435
+39.351.9617779
8.30-12.30 / 15.00-19.00
Sabato pomeriggio chiuso
LIBRERIA STUDIUM
Libreria medica internazionale
- PADOVA -
LIBRERIA STUDIUM
0,00 €
Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents
Jann, Penzak, Cohen,
Editore
Springer
Anno
2016
Pagine
601
ISBN
9783319278810
150,00 €
I prezzi indicati possono subire variazioni poiché soggetti all'oscillazione dei cambi delle valute e/o agli aggiornamenti effettuati dagli Editori.

This book is a comprehensive resource on psychotropic medications, detailing the latest methods for defining their characteristics, their use in different patient populations, and drug-drug interactions; an important collection of information forclinicians, students, researchers, and members of the pharmaceutical industry alike.

The first section provides the foundational principles of these drugs. Mathematical modeling of parameters that affect their entryto,and exit from, the central nervous system (CNS) compartment are presented on an individual basis and then applied to target populations with specific disease states. Methods and characteristics that inform the transfer of these drugs from the laboratory bench to use in patient care are discussed, including imaging techniques, genetics and physiological barriers, such as the blood-brain barrier. The second section describes the characteristics of specific agents,nominally arranged intodifferent therapeutic categories and with reference crossover use in different disease states. The pharmacologic characteristics of different drug formulations are explored in the context of their ability to improve patient adherence. The third section focuses on drug-drug interactions.Psychotropic medications from different categories are frequently prescribed together,or alongside medications used to treat comorbid conditions, and the information provided is directly relevant to the clinic, as a result.

The clinical application of pharmacokinetics and pharmacodynamics of CNS agents has made significant progress over the past 50 years and new information is reported by numerous publications in psychiatry, neurology, and pharmacology.Our understanding of the interrelationship between these medications, receptors, drug transporters, as well as techniques for measurement and monitoring their interactions,isfrequently updated. However, with information presented on a host of different platforms, and in different formats, obtaining the full picture can be difficult. This title aims to collate this information into a single source that can be easily interpreted and applied towards patient care by the clinical practitioner, and act as a reference for all others who have an interest in psychopharmacological agents.

  • Pharmacokinetic Properties

    Luer, Mark S. (et al.)

    Pages 3-27

  • Pharmacodynamics

    Rojas-Fernandez, Carlos H.

    Pages 29-48

  • Positron Emission Tomography (PET) Use in Pharmacology

    Nye, Jonathon A. (et al.)

    Pages 49-70

  • Population Pharmacokinetics

    Chaturvedula, Ayyappa

    Pages 71-90

  • Drug Transporters

    Penzak, Scott R.

    Pages 91-119

  • Pharmacogenomics

    Wiese, Kristen M. (et al.)

    Pages 121-135

  • Antipsychotics

    Jann, Michael W. (et al.)

    Pages 139-175

  • Mood Stabilizers

    Spina, Edoardo (et al.)

    Pages 177-203

  • Antidepressants

    Finley, Patrick R. (et al.)

    Pages 205-245

  • Clinical Pharmacokinetics and Pharmacodynamics of Anxiolytics and Sedative/Hypnotics

    DeVane, C. Lindsay

    Pages 247-266

  • Opioid Analgesics

    Guthrie, Sally K. (et al.)

    Pages 267-301

  • Stimulants and Other Non-stimulants for Attention-Deficit/Hyperactivity Disorder (ADHD)

    Markowitz, John S. (et al.)

    Pages 303-327

  • Antidementia Drugs

    VanDenBerg, Chad M. (et al.)

    Pages 329-349

  • Anti-addiction Agents

    Jann, Michael W.

    Pages 351-372

  • Anesthetic Drugs Pharmacokinetics and Pharmacodynamics

    Jann, Michael W.

    Pages 373-394

  • Clinically Significant Interactions with Antipsychotics

    Lu, Mong-Liang (et al.)

    Pages 397-421

  • Clinically Significant Interactions with Mood Stabilisers

    Taylor, David (et al.)

    Pages 423-449

  • Clinically Significant Interactions with Antidepressants

    Lam, Y. W. Francis

    Pages 451-469

  • Clinically Significant Interactions with Benzodiazepines

    Valdes, Jose (et al.)

    Pages 471-495

  • Clinical Significant Interactions with Opioid Analgesics

    Kiang, Tony K. L. (et al.)

    Pages 497-534

  • Clinically Significant Interactions with Stimulants and Other Non-stimulants for ADHD

    Kattura, Rania S. (et al.)

    Pages 535-549

  • Clinically Significant Interactions with Cholinesterase Inhibitors and Other Antidementia Agents

    VanDenBerg, Chad M.

    Pages 551-563

  • Clinically Significant Interactions with Anti-addiction Agents

    Coller, Janet K. (et al.)

    Pages 565-577

  • Clinically Significant Interactions with Anesthetic Agents

    Jann, Michael W.

    Pages 579-601

 

Informazioni

Non ci sono recensioni

Dettaglio
Aggiungi la tua recensione

Ultimi prodotti

Risonanza magnetica 2a edizione
Rummeny, Reimer, Heindel
237,00 € 200,00 €
L’Esame visivo efficace
Giannelli, Moro
65,00 €
Atlante di Shiatsu 2a edizione
Rappenecker, Kockrick
29,00 €